Biotechnology - Biotechnology, Women's Health

Filter

Popular Filters

Ligand enters global license deal for women's health product

23-07-2013

Ligand Pharmaceuticals (Nasdaq: LGND) announces the signing of a global license agreement with recently-formed…

Azure BiotechBiotechnologyGloballasofoxifeneLicensingLigand PharmaceuticalsPfizerPharmaceuticalWomen's Health

New data on Amgen's Prolia and Merck & Co's odanacatib presented at ASBMR meeting

15-10-2012

Amgen (Nasdaq: AMGN), the world's largest biotech firm, has presented data from several Prolia (denosumab)…

AmgenAnti-Arthritics/RheumaticsBiotechnologyMerck & CoodanacatibPharmaceuticalProliaResearchWomen's Health

BioSante female libido drug flops in Ph III studies

16-12-2011

its two pivotal Phase III LibiGel (testosterone gel) efficacy trials, joining the list of failures in…

BioSante PharmaceuticalsBiotechnologyLibiGelResearchWomen's Health

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top